NY, NY -- (SBWIRE) -- 05/09/2017 -- Antiviral Drugs Market 2017

About Antiviral Drugs
Antiviral drugs are agents used to cure a viral infection by inhibiting the growth of viral pathogens. There are two types of antiviral agents which includes narrow-spectrum antiviral agents and broad-spectrum antiviral agents.

The analysts forecast the global antiviral drugs market to grow at a CAGR of 9.48% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global antiviral drugs market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of antiviral drugs.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/1120093-global-antiviral-drugs-market-2017-2021

The report, Global Antiviral Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Bristol-Myers Squibb
- F. Hoffmann-La Roche
- Gilead Sciences
- GlaxoSmithKline

Other prominent vendors
- AbbVie
- Johnson & Johnson
- Merck
- Novartis

Market driver
- Stockpiling by public healthcare agencies
- For a full, detailed list, view our report

Market challenge
- Need for proper storage conditions of antiviral drugs
- For a full, detailed list, view our report

Market trend
- Technological advancements
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Complete Report Details @ https://www.wiseguyreports.com/reports/1120093-global-antiviral-drugs-market-2017-2021

Table of Contents

PART 01: Executive summary
PART 02: Research Methodology

PART 03: Introduction
- Key market highlights
- Key vendor offerings

PART 04: Disease Overview
- Viral disease

PART 05: Market landscape
- Market overview
- Five forces analysis

PART 06: Pipeline analysis

PART 07: Market segmentation by therapies
- Global hepatitis therapeutics market
- Global HIV/AIDS therapeutics market
- Global herpes therapeutics market
- Global influenza therapeutics market

PART 08: Market segmentation by MOA
- Reverse transcriptase inhibitors
- Protease inhibitors
- Entry/Fusion inhibitors
- Immune system modulators

PART 09: Geographical segmentation
- Antiviral drugs market in Americas
- Antiviral drugs market in EMEA
- Antiviral drugs market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges
- Market drivers
- Impact of drivers on key customer segments
- Market challenges
- Forcefield analysis of impact of drivers and challenges

PART 12: Market trends
- Technological advancements
- Combination therapy
- Mergers and acquisitions
- Growing partnerships
...…..Continued

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1120093